Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Antibodies to watch in 2024
mAbs ( IF 5.3 ) Pub Date : 2024-01-05 , DOI: 10.1080/19420862.2023.2297450 Silvia Crescioli 1 , Hélène Kaplon 2 , Alicia Chenoweth 3 , Lin Wang 4 , Jyothsna Visweswaraiah 5 , Janice M. Reichert 1
mAbs ( IF 5.3 ) Pub Date : 2024-01-05 , DOI: 10.1080/19420862.2023.2297450 Silvia Crescioli 1 , Hélène Kaplon 2 , Alicia Chenoweth 3 , Lin Wang 4 , Jyothsna Visweswaraiah 5 , Janice M. Reichert 1
Affiliation
The ‘Antibodies to Watch’ article series provides an annual summary of commercially sponsored monoclonal antibody therapeutics currently in late-stage clinical development, regulatory review, and t...
中文翻译：
2024 年值得关注的抗体
“值得关注的抗体”系列文章提供了目前处于后期临床开发、监管审查和测试阶段的商业赞助单克隆抗体疗法的年度摘要。
更新日期：2024-01-07
中文翻译：
2024 年值得关注的抗体
“值得关注的抗体”系列文章提供了目前处于后期临床开发、监管审查和测试阶段的商业赞助单克隆抗体疗法的年度摘要。
京公网安备 11010802027423号